ACM
PFE icon

ADAR1 Capital Management’s Pfizer PFE Stock Holding History

ADAR1 Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.08M Buy
252,400
+175,000
+226% +$4.58M 0.28% 84
2026
Q1 		$2.17M Buy
77,400
+5,000
+7% +$133K 0.13% 119
2025
Q4 		$1.8M Buy
72,400
+28,000
+63% +$706K 0.13% 105
2025
Q3 		$1.13M Buy
44,400
+5,000
+13% +$123K 0.11% 97
2025
Q2 		$955K Sell
39,400
-1,650
-4% -$38.5K 0.15% 85
2025
Q1 		$1.04M Buy
41,050
+6,000
+17% +$157K 0.19% 80
2024
Q4 		$930K Sell
35,050
-900
-3% -$24.4K 0.19% 83
2024
Q3 		$1.04M Sell
35,950
-4,000
-10% -$117K 0.17% 72
2024
Q2 		$1.12M Sell
39,950
-66,392
-62% -$1.83M 0.21% 62
2024
Q1 		$2.95M Buy
106,342
+88,942
+511% +$2.47M 0.67% 29
2023
Q4 		$501K Buy
+17,400
New +$526K 0.18% 60

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ADAR1 Capital Management's PFE Position: Q2 2026 in Review

ADAR1 Capital Management increased its Pfizer (PFE) stake by 226% in Q2 2026, buying an estimated $4.58M and bringing the position to 252,400 shares worth $6.08M. The position accounts for 0.28% of the portfolio, ranked #84.

ADAR1 Capital Management first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • ADAR1 Capital Management held 252,400 shares of Pfizer worth $6.08M as of Q2 2026.
  • ADAR1 Capital Management bought 175,000 Pfizer shares in Q2 2026, an estimated $4.58M.
  • Pfizer made up 0.28% of ADAR1 Capital Management's portfolio in Q2 2026, its #84 holding.
  • ADAR1 Capital Management first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.